FDA Inspection
CIMBAR PERFORMANCE MINERALS, INC.CIMBAR PERFORMANCE MINERALS, INC. – FDA Inspection, Feb 3, 2017
Record Details
This FDA Inspection record concerns CIMBAR PERFORMANCE MINERALS, INC., with an inspection on February 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b77e5690-fd3f-485b-822a-d341a4f029fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005647
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 212.20(d)Determination need for investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CIMBAR PERFORMANCE MINERALS, INC.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2025 | Not classified | Atlanta District Office | |
| January 30, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CIMBAR PERFORMANCE MINERALS, INC.
- FDA Inspection 1275942 - 2025-07-18
- FDA Inspection 1120887 - 2020-01-30
- FDA Inspection 924339 - 2015-04-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.